Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact on Atrial Remodeling of Dapaglifozin in Patients With Heart Failure .

NCT04707352 is registered in ClinicalTrials.gov with Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia as lead sponsor.

NCT NCT04707352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04707352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact on Atrial Remodeling of Dapaglifozin in Patients With Heart Failure .
Lead sponsor
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Phase
Phase 3
Overall status
Completed
Start date
February 8, 2021
Completion date
March 26, 2023
Enrollment
162 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure